NASDAQ:REGN   Regeneron Pharmaceuticals, Inc
Based on fundamental analysis from trusted expert source.

'Regeneron have been one of the few companies mentioned in the press since the pandemic began, for having an effective anti viral drug for treating the symptoms of Covid.'

Recently mentioned and used in treating US President.

Possible break through prior ATH resistance of August 2015. Averages up. Appears to be moving up after recent return to zone between MAs.

False breakout above 600, could turn over and if 500 fails this trade is void.

Aggressive entry is now as hit 664 in July, more conservative entry would be to wait for price to stay above 600.